Keyphrases
Acid Activation
100%
Free Fatty Acids
100%
Non-alcoholic Fatty Liver Disease (NAFLD)
100%
Steatotic
100%
L02 Cells
100%
ERp57
100%
Steatosis
28%
Liver Disease Progression
28%
Liver Biopsy
28%
L-02
28%
Differentially Expressed Proteins
14%
Up-regulated Proteins
14%
Proteomics
14%
Small Interfering RNA (siRNA)
14%
Normal Human
14%
Liver
14%
Proteomic Analysis
14%
Knockdown
14%
Human Liver
14%
Immunohistochemistry
14%
RNA Interference
14%
Protein Expression Level
14%
Hepatocytes
14%
Two-dimensional Gel Electrophoresis
14%
Cultured Cells
14%
Reduced Fat
14%
Human Hepatocytes
14%
Fat Accumulation
14%
Inflammation Grade
14%
Hepatic Cells
14%
Fibrosis Stage
14%
Inflammatory Fibrosis
14%
Medicine and Dentistry
Fatty Acid
100%
Nonalcoholic Fatty Liver
100%
Proteomics
28%
Disease Course
28%
Biopsy Technique
28%
Hepatocyte
28%
Liver Biopsy
28%
Steatosis
28%
Upregulation
14%
Protein Expression
14%
RNAI
14%
Immunohistochemistry
14%
Small Interfering RNA
14%
Lipid Storage
14%
Fibrosis
14%
Two Dimensional Gel Electrophoresis
14%
L-02 Cell Line
14%
Immunology and Microbiology
Proteomics
100%
Two-Dimensional Gel Electrophoresis
50%
Upregulation
50%
Normal Human
50%
Lipid Storage
50%
Protein Expression Level
50%
RNAI
50%
L-02 Cell Line
50%
Pharmacology, Toxicology and Pharmaceutical Science
Fatty Acid
100%
Nonalcoholic Fatty Liver
100%
Disease Course
28%
Steatosis
28%
Inflammation
14%
Small Interfering RNA
14%
Normal Human
14%
Fibrosis
14%
Two Dimensional Polyacrylamide Gel Electrophoresis
14%